Thomas Miller is the founder of Entos. Entos has raised $206M in total funding. Latest round: Series A. Backed by Coatue, Catalio Capital Management, OrbiMed.
Thomas Miller is the Co-founder and CEO of Entos (now known as Iambic Therapeutics), a biotechnology company combining AI-driven drug discovery with automated high-throughput experimentation. He is a theoretical chemist who also serves as a Visiting Associate at Caltech. Miller focuses on the intersection of AI, chemistry, and biology to accelerate small-molecule therapeutics development.
Full founder directory · Investor directory · Company funding database · Fundraising library